Institute events

RSS feed

Institute seminar – 27 March – Genevieve Gourdon (France)

DMSXL mouse model of myotonic dystrophy type 1: past, present and future Monday 27 March 2017 – 12:00-13:00 Genevieve Gourdon (Imagine Institute) Host : Denis Furling Institute of Myology auditorium Hôpital de la Pitié-Salpêtrière Building Babinski Entrance 82 bd Vincent Auriol metro Chevaleret

Martine Barkats and Maria Grazia Biferi awarded the Avi Kremer ALS Treatment Prize from Prize4Life for their gene therapy approach

Martine Barkats and Maria Grazia Biferi have received the Avi Kremer ALS Treatment Prize from Prize4Life, which is committed to the fight against Amyotrophic Lateral Sclerosis (ALS*) and awards $1 million to the winners. Within the Myology Research Centre (MRC) of the Institute of Myology, the team “CNS Gene Transfer & Biotherapy of Motor Neuron … [Read more]

Institute seminar – 13 March – Dada Pisconti Ph.D. (UK)

Of genes, sugars and proteins: a journey into the muscle stem cell niche Dada Pisconti Ph.D. (Department of Biochemistry,Centre for Glycobiology, Institute of Integrative Biology, University of Liverpool, UK) Monday 13 March 2017 – 12:00-13:00 Host : Fabien Le Grand Institute of Myology auditorium Hôpital de la Pitié-Salpêtrière Building Babinski Entrance 82 bd Vincent Auriol metro … [Read more]

Institute seminar – 1st march – Dr. Andreas Roos (UK)

Mass spectrometry based protein quantitation towards the understanding of the molecular pathology of complex myopathies Dr. Andreas Roos (Neuromuscular Group, Institute of Genetic Medecine, University of Newcastle, UK) Wednesday 1st Mars 2017 – 14:00-15:00 Host : Gillian Butler-Browne Charcot auditorium (next to Babinski building) Hôpital de la Pitié-Salpêtrière Entrance 82 bd Vincent Auriol metro Chevaleret

Institute seminar – 27 February – Marie Castets (France)

Towards characterization of ADAMTSL1 as a new matrix protein involved  in skeletal muscle regeneration and in rhabdomyosarcoma Marie Castets (Cancer Center of Lyon (CRCL), France) Monday 27 February 2017 – 12:00-13:00 Host : Valérie Allamand Institute of Myology auditorium Hôpital de la Pitié-Salpêtrière Building Babinski Entrance 82 bd Vincent Auriol metro Chevaleret

Prize4Life Announces ALS Treatment Prize Winner

Prize4Life, a nonprofit organization whose mission is to accelerate the discovery of treatments and a cure for ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig’s disease), today announced the winner of its $1M Avi Kremer ALS Treatment Prize. The winners are the team of Drs. Martine Barkats and Maria-Grazia Biferi, from the Institute of … [Read more]

EVELAM: the result of a fruitful collaboration between myology experts from Latin America and Europe that will benefit myology at the international level

Interview with one of its founders, Dr. Jorge Bevilacqua Jorge Bevilacqua is an Argentinean physician and researcher who has been practicing for 20 years in Santiago de Chile at the Hospital Clinico Universidad de Chile. His involvement with the Institute of Myology is very old: he studied at the Institute of Myology’s Summer School in … [Read more]

Spinraza drug authorization: Patients’ organization AFM-Telethon welcomes a major step but calls upon full transparency by Biogen regarding the price claimed

On December 23rd 2016, the US Food and Drug Administration (FDA) issued Biogen with an authorization for Spinraza (Nusinersen). The drug is approved for use for all American patients affected with spinal muscular atrophy (SMA), regardless of disease type. AFM-Telethon welcomes this landmark development which opens the way for treating an incurable, devastating and extremely … [Read more]

Optimizing therapeutic approach to cure Duchenne Muscular Dystrophy

Team 5 from institute’s Myology Center for Research “RNA-repair based therapeutics & skeletal muscle pathophysiology” is directed by France Pietri-Rouxel. Focused on Duchenne muscular dystrophy, it is involved in translational research: from basic research to clinical trials. Within the team, four thematic groups, which include engineers, technical staff and students, are led by four researchers. … [Read more]

Glycogenoses: information and meeting days for families

Organised during the general assembly of the Association Francophone des Glycogénoses (French Association for Glycogenoses, AFG) families and research stakeholders involved in glycogenoses were brought together over two days. Meetings with families (Rencontres des familles), organised by the AFG on October 22 and 23 in Lyon, allowed researchers, medical teams, reference centres for rare diseases … [Read more]